GH Research
GHRS • NASDAQ
GH Research is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Velichka Valcheva, with a market cap of $947.2M.
Market Cap$947.2M
Employees49.0
CEOVelichka Valcheva
CountryIreland
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
GHR
GH Research FAQ
Common questions about GH Research
GH Research is scheduled to report earnings for Q1 2026 on May 7, 2026.
GH Research has approximately 49 employees.